HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Shiseido/Stila

This article was originally published in The Rose Sheet

Executive Summary

Joint venture will bring Stila cosmetics line to Japanese market in the fall. Stila Cosmetics products will be marketed through InterAct, a wholly owned subsidiary of Shiseido, which was created in June 1997. The cosmetics line will be launched in five prestige stores, including Hankyu (in Osaka) in August, Daimaru (Shinsaibashi) in September and Mitsakoshi (Ginza) in October. Stila hopes to open up to 40 doors throughout Japan within five years. Shiseido's projected sales volume for Stila Cosmetics in Japan is approximately $3.3 mil. in the first year. Founded in 1994, Los Angeles-based Stila's retail sales topped $15 mil. in 1997, while projected retail sales for 1998 are expected to exceed $20 mil. Stila cosmetics are sold in more than 40 U.S. doors, including Barneys New York, Saks Fifth Avenue and Nordstrom stores...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS005653

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel